Latest filing published 28 Jun 2022 for India Globalization Capital, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John Edward LYNCH: trading record in brief
John Edward LYNCH is a declared insider of IGC Pharma, Inc. (board member), with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 31 May 2022 and the latest from 1 June 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 28 June 2022, the filings show an option exercise in IGC Pharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Edward LYNCH
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,125 shares0COMMON STOCKSEC:0001185185-22-000782:0
1 of 1 declaration
